Amotl2 was described with a dual tumour suppressive function by targeting both Yap (known as anti‐apoptosis transcription factor) and Akt (which contributes to impaired apoptosis in cancer) (Han et al., 2017). The gene discussed is AMOTL2; the disease is cancer.